Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jan Breza
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After Nephrectomy
New England Journal of Medicine
Medicine
Related publications
Adjuvant Therapy After Nephrectomy for Renal Cell Carcinoma
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Phase III Trial of Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Clinical Cancer Research
Cancer Research
Oncology
The Current State of Adjuvant Therapy Following Surgery for High-Risk Renal Cell Carcinoma
European Urology Focus
Urology
Pancreatic Metastasis of Renal Cell Carcinoma Occurring 17 Years After Nephrectomy
The journal of the Japanese Practical Surgeon Society
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial
The Lancet
Medicine
Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma
Current Oncology
Oncology
A Case of Endobronchial Metastasis From Renal Cell Carcinoma 7 Years After Nephrectomy
Tuberculosis and Respiratory Diseases
Pulmonary
Infectious Diseases
Respiratory Medicine
A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma
Case Reports in Oncological Medicine
Oncology
